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. LC-ESI-HRMS analysis of genD2-genS2-genN-genD1 knock-out mutants. Related to Figure 2 . Schematic representation of the in-frame deletions and complementations, and Southern blot confirmations are shown for each mutant. The arrows indicate the expected size of the fragments from the wild-type and mutants chromosomal DNA, respectively.
A. ΔgenD2
B. ΔgenS2 Primer pairs for amplification of left-or right-flanking fragments of a target gene, for PCR/sequencing confirmation, for complementation plasmid construction, and for cloning target genes for over-expression are marked with suffixes -L1/-L2, -R1/-R2, -a/-b, CK1/CK2, or -For/-Rev, respectively. 
List of bacterial strains and plasmids used in this study
Structures of 3''-dehydro-3''-amino-gentamicin A2 and its homologs, kanamycin B, tobramycin and sisomicin.
Purification of gentamicin A2
Purification of gentamicin A2 (3) from extracts of the ΔgenS2ΔgenK mutant fermentation broth after cation exchange (see Experimental Procedures) was performed on a Waters 2535 semi-preparative HPLC system using a ZORBAX SB-C18 (9.4 × 250 mm, 5μ, Agilent) semi-preparative column, with as mobile phase (A) 0.2% TFA in water adjusted to pH 2 with NH 4 OH and (B) acetonitrile. Elution of gentamicin A2 was carried out isocratically at 95% A for 15 min at a flow rate of 4 ml/min. The column eluate was directed to an Evaporative Light Scattering Detector(ELSD, Alltech 3300) with 2ml/min splitting, and the rest of the eluate was collected in 1 ml fractions. The atomization temperature of ELSD was 55°C and the drift tube temperature was 48 °C. Fractions containing gentamicin A2 were pooled and further confirmed by LC-ESI-HRMS.
Kinetic study of GenN with kanamycin B
8.5 nM GenN was incubated in 500 μl Tris-HCl (50 mM, pH 7.5) buffer at 30°C with kanamycin B (11) at concentrations of 30, 40, 50, 60 and 70 μM in the presence of 250 μM SAM. An 80 μl aliquot of each reaction was taken out after 1, 2, 3, 4, 5 and 6 min incubation and mixed immediately with an equal volume of ice cold chloroform to precipitate the enzyme. The reactions were analyzed by LC-ESI-MS. The product 3''N-methylkanamycin B (17) was quantified based on the peak integration of the selected ion. Data points are the mean value of three replicates.
Conditions for LC-ESI-MS analyses
LC-ESI-HRMS analysis of gentamicin-related metabolites and in vitro assays were performed on a Thermo LTQ-Orbitrap XL instrument using a Luna C18 column (250 mm × 4.6 mm, 5 μ, Phenomenex) with a flow rate of 0.4 ml/min. LC-MS analysis of proteins was carried out on a ThermoFinnigan LCQ fitted with an ESI source connected to an Agilent HP 1100 HPLC system using a Nucleosil C4 column (250 mm × 2 mm, 5 μ, Macherey-Nagel). The mobile phase and gradients used for HPLC are as follows:
HPLC gradient used for analysis of gentamicin-related metabolites
Mobile phase A: 0.2% TFA in water; Mobile phase B: acetonitrile. 2% B to 14% B over 18 min, then to 90 % B within 1 min, maintained at 90% B for 5 min, returned to 2% B over 1 min and maintained at 2% B for a further 5 min. The injection volume was 5 μl for each gentamicin standard (500 μg ml -1 ) and 20 μl for each sample. Each cultivation and analysis was performed in triplicate.
HPLC gradient for analysis of aminoglycosides in enzymatic assays
Mobile phase A: 0.2% TFA in water; Mobile phase B: 0.1% TFA in acetonitrile. 2%B to 8%B over 9 min then to 90%B over 1 min, maintained at 90%B for 4 min, returned to 2%B over 1 min and then maintained at 2%B for a further 5 min. flow rate 0.6 ml/min.
HPLC gradient for analysis of 5'-deoxydenosine in enzymatic assays
Mobile phase A: 0.1% TFA in water; Mobile phase B: 0.1% TFA in acetonitrile. 0%B to 20% B over 30 min. 0.6 ml/min.
HPLC gradient for analysis of proteins
Mobile phase A: 0.1% TFA in water; Mobile phase B: 0.1% TFA in acetonitrile. 35% B to 45 % B over 5 min, increasing gradient of B to 75% over 20 min, gradient to 95% within 2 min, maintained at 95% B for 7 min, followed by a gradient from 95% B to 35%B within 3 min;
